Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,301 warrant series at 1,050 companies. 774 in the money, 58 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Redeemable Warrants (Lee Pinkerton convertible note) | $3.47 | $2.8M | 20-F, Mar 20, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Public Warrants (SMXWW) – former Lionheart public and private warrants | $3.47 | $2.8M | F-3, Jul 1, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| RBW May 2025 Underwriter (Placement Agent) Warrants | $3.47 | $2.8M | 20-F, Mar 20, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series A Common Warrants (Aegis Private Placement, September 2024) | $3.47 | $2.8M | 20-F, Mar 20, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Steven Wallitt Warrants (February 2024 term sheet) | $3.47 | $2.8M | 20-F, Mar 20, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Private Placement Warrants (Cetus Sponsor LLC; from Cetus private units) | $0.0770 | $2.8M | 20-F, Apr 30, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Public Warrants (MKDWW; former Cetus Capital public warrants from IPO units) | $0.0770 | $2.8M | 20-F, Apr 30, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Sept 2025 SPA Due Diligence Warrants – Fourth Closing (Loan #40) | $1.00 | $2.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Sept 2025 SPA Due Diligence Warrants – Initial Closing (Loan #34) | $1.00 | $2.8M | 10-K, Apr 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Sept 2025 SPA Due Diligence Warrants – Second Closing (Loan #38) | $1.00 | $2.8M | 10-K, Apr 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Sept 2025 SPA Due Diligence Warrants – Third Closing (Loan #39) | $1.00 | $2.8M | 10-K, Apr 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Sept 2025 SPA Investor Warrants – Fourth Closing (Loan #37) | $1.00 | $2.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Sept 2025 SPA Investor Warrants – Initial Closing (Loan #33) | $1.00 | $2.8M | 10-K, Apr 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Sept 2025 SPA Investor Warrants – Second Closing (Loan #35) | $1.00 | $2.8M | 10-K, Apr 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Sept 2025 SPA Investor Warrants – Third Closing (Loan #36) | $1.00 | $2.8M | 10-K, Apr 16, 2026Dilution tabAs of Nov 18, 2026 | ||||||||
| Underwriter (Representative's) Warrants – February 2025 Public Offering | $1.00 | $2.8M | 424B5, Nov 18, 2025Dilution tabAs of Nov 18, 2026 | ||||||||
| August 2026 Pre-Funded Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| December 2025 PIPE Placement Agent Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| December 2025 PIPE Series C Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| December 2025 PIPE Series D Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| January 2025 PIPE Placement Agent Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| January 2025 PIPE Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| January 2025 Repriced PIPE Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| March 2023 Offering Placement Agent Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| March 2025 Financial Advisor Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| March 2025 Warrant Inducement Series A | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| March 2025 Warrant Inducement Series B | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| May 2023 PIPE Placement Agent Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| May 2024 Placement Agent Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| May 2024 Series A Common Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| November 2023 Placement Agent Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| September 2024 PIPE Placement Agent Warrants | $0.5701 | $2.8M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| 2025 warrants (November 15, 2023 subscription agreement) | $0.4998 | $2.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| 2026 warrants (July 6, 2026 Regulation S unit private placement) | $0.4998 | $2.8M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| IPO Underwriter's Warrant (Network 1 Financial Securities, Inc.) | $2.09 | $2.8M | 20-F, Aug 31, 2026Dilution tabAs of Oct 21, 2026 | ||||||||
| December 2022 Warrants (remaining non-exchanged warrant) | $1.63 | $2.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Milestone Warrants (February 2026 public offering common warrants, ERNAW) | $1.63 | $2.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Pre-funded warrants (October 2024 and 2025 SPA series, $1.88) | $1.63 | $2.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Q1-22 Warrants (March 2022 private placement common stock warrants) | $1.63 | $2.8M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| December 2024 PA Warrants (placement agent compensation warrants, December 2024 registered direct offering) | $1.71 | $2.7M | F-3/A, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| July 2024 PA Warrants (placement agent compensation warrants, July 2024 warrant inducement) | $1.71 | $2.7M | F-3/A, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| July 2024 Series A-1 Warrants (warrant inducement transaction) | $1.71 | $2.7M | F-3/A, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| October 2023 PA Warrants (placement agent compensation warrants, October 2023 registered direct offering) | $1.71 | $2.7M | F-3/A, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| September 2025 Investor Warrants (Series B / Ordinary Warrants) | $1.71 | $2.7M | F-3/A, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| September 2025 PA Warrants (placement agent compensation warrants, September 2025 public offering) | $1.71 | $2.7M | F-3/A, Nov 6, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants granted during the six months ended June 30, 2026 — $1.30 exercise price, nonemployee marketing relationship | $0.7000 | $2.7M | 10-Q, Aug 14, 2026Dilution tabAs of Aug 30, 2026 | ||||||||
| Warrants outstanding at January 1, 2026 (legacy series carried into 2026) | $0.7000 | $2.7M | 10-Q, Aug 14, 2026Dilution tabAs of Aug 30, 2026 | ||||||||
| April 2025 Placement Agent Warrants (Dominari, $4.50) | $0.1619 | $2.7M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| April 2025 Placement Agent Warrants (Madison, $4.50) | $0.1619 | $2.7M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| April 2026 Placement Agent Warrants (Madison, originally $1.00) | $0.1619 | $2.7M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 |
LP Redeemable Warrants (Lee Pinkerton convertible note)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
Public Warrants (SMXWW) – former Lionheart public and private warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
RBW May 2025 Underwriter (Placement Agent) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
Series A Common Warrants (Aegis Private Placement, September 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
Steven Wallitt Warrants (February 2024 term sheet)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
MKDWMKDWELL Tech Inc. Ordinary Share$0.0770Last price
Private Placement Warrants (Cetus Sponsor LLC; from Cetus private units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
MKDWMKDWELL Tech Inc. Ordinary Share$0.0770Last price
Public Warrants (MKDWW; former Cetus Capital public warrants from IPO units)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Due Diligence Warrants – Fourth Closing (Loan #40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Due Diligence Warrants – Initial Closing (Loan #34)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Due Diligence Warrants – Second Closing (Loan #38)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Due Diligence Warrants – Third Closing (Loan #39)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Investor Warrants – Fourth Closing (Loan #37)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Investor Warrants – Initial Closing (Loan #33)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Investor Warrants – Second Closing (Loan #35)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Sept 2025 SPA Investor Warrants – Third Closing (Loan #36)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
NXXTNextNRG Inc.$1.00Last price
Underwriter (Representative's) Warrants – February 2025 Public Offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
August 2026 Pre-Funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
December 2025 PIPE Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
December 2025 PIPE Series C Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
December 2025 PIPE Series D Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
January 2025 PIPE Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
January 2025 PIPE Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
January 2025 Repriced PIPE Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
March 2023 Offering Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
March 2025 Financial Advisor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
March 2025 Warrant Inducement Series A
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
March 2025 Warrant Inducement Series B
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
May 2023 PIPE Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
May 2024 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
May 2024 Series A Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
November 2023 Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
DRMADermata Therapeutics, Inc.$0.5701Last price
September 2024 PIPE Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
SGLYSingularity Future Technology Ltd.$0.4998Last price
2025 warrants (November 15, 2023 subscription agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
SGLYSingularity Future Technology Ltd.$0.4998Last price
2026 warrants (July 6, 2026 Regulation S unit private placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
POASPhaos Technology Holdings (Cayman) Limited$2.09Last price
IPO Underwriter's Warrant (Network 1 Financial Securities, Inc.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
ERNAErnexa Therapeutics Inc.$1.63Last price
December 2022 Warrants (remaining non-exchanged warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
ERNAErnexa Therapeutics Inc.$1.63Last price
Milestone Warrants (February 2026 public offering common warrants, ERNAW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
ERNAErnexa Therapeutics Inc.$1.63Last price
Pre-funded warrants (October 2024 and 2025 SPA series, $1.88)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
ERNAErnexa Therapeutics Inc.$1.63Last price
Q1-22 Warrants (March 2022 private placement common stock warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.8M
PPBTPurple Biotech Ltd. American Depositary Shares$1.71Last price
December 2024 PA Warrants (placement agent compensation warrants, December 2024 registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
PPBTPurple Biotech Ltd. American Depositary Shares$1.71Last price
July 2024 PA Warrants (placement agent compensation warrants, July 2024 warrant inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
PPBTPurple Biotech Ltd. American Depositary Shares$1.71Last price
July 2024 Series A-1 Warrants (warrant inducement transaction)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
PPBTPurple Biotech Ltd. American Depositary Shares$1.71Last price
October 2023 PA Warrants (placement agent compensation warrants, October 2023 registered direct offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
PPBTPurple Biotech Ltd. American Depositary Shares$1.71Last price
September 2025 Investor Warrants (Series B / Ordinary Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
PPBTPurple Biotech Ltd. American Depositary Shares$1.71Last price
September 2025 PA Warrants (placement agent compensation warrants, September 2025 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
KWIKKwikClick, Inc.$0.7000Last price
Warrants granted during the six months ended June 30, 2026 — $1.30 exercise price, nonemployee marketing relationship
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
KWIKKwikClick, Inc.$0.7000Last price
Warrants outstanding at January 1, 2026 (legacy series carried into 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
AUIDauthID Inc.$0.1619Last price
April 2025 Placement Agent Warrants (Dominari, $4.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
AUIDauthID Inc.$0.1619Last price
April 2025 Placement Agent Warrants (Madison, $4.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
AUIDauthID Inc.$0.1619Last price
April 2026 Placement Agent Warrants (Madison, originally $1.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$2.7M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,062 dilution snapshots. 4,848 of 5,301 series state an exercise price and 3,365 an expiry date. 130 record when exercise begins; that count grows as companies are re-extracted. 631 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.